Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The lymphatic system is the primary pathway of metastasis for most human cancers. Recent research efforts in studying lymphangiogenesis have suggested the existence of a relationship between lymphatic vessel density and patient survival. However, current methodology of lymphangiogenesis quantification is still characterised by high intra- and interobserver variability. For the amount of lymphatic vessels in a tumour to be a clinically useful parameter, a reliable quantification technique needs to be developed. With this consensus report, we therefore would like to initiate discussion on the standardisation of the immunohistochemical method for lymphangiogenesis assessment.

Original publication




Journal article


Br J Cancer

Publication Date





1611 - 1625


Biomarkers, Tumor, Endothelial Cells, Humans, Immunoenzyme Techniques, Lymphangiogenesis, Lymphatic Metastasis, Lymphatic Vessels, Membrane Glycoproteins, Neoplasms, Vascular Endothelial Growth Factor A